- Ongoing support of the 'White House Challenge to Save Lives from Overdose' through workplace and public safety measures
- One-year mark of Ready to Rescue public awareness campaign to expand awareness, particularly among young adults and vulnerable communities
- 20,000 additional doses of NARCAN® Nasal Spray to be donated to organizations in need
GAITHERSBURG, Md., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) remains committed to supporting widespread opioid emergency preparedness by expanding access to NARCAN
® Nasal Spray and educating the public on how to respond to an opioid overdose. As opioid overdose fatalities have risen in the workplace in recent years,
1 Emergent is working with businesses to prepare for accidental opioid emergencies by ensuring workplaces, facilities, and hospitality venues, among many other locations, should consider being equipped with NARCAN
® Nasal Spray. In March 2024, Emergent joined the 'White House Challenge to Save Lives from Overdose', a nationwide call encouraging leaders to commit to increasing education of and access to life-saving opioid overdose reversal medications.